Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.

about

Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.

Item

http://www.wikidata.org/entity/Q40396447

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Platinum plus bortezomib for t ...... edullary carcinoma: Two cases.

@en

type

Item

label

Platinum plus bortezomib for t ...... edullary carcinoma: Two cases.

@en

prefLabel

Platinum plus bortezomib for t ...... edullary carcinoma: Two cases.

@en

P1476

Platinum plus bortezomib for t ...... edullary carcinoma: Two cases.

@en

P2093

Adina Alazraki

http://www.w3.org/2001/XMLSchema#string

Holly Meany

http://www.w3.org/2001/XMLSchema#string

Hong Yin

http://www.w3.org/2001/XMLSchema#string

Louis B Rapkin

http://www.w3.org/2001/XMLSchema#string

Stephen Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Renal medullary carcinoma. The seventh sickle cell nephropathy

Gene expression profiling of renal medullary carcinoma: potential clinical relevance.

Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).

A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors.

Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.

History of the development of the classification of renal cell neoplasia.

2004 WHO classification of the renal tumors of the adults.

Renal medullary carcinoma: report of seven cases from Brazil.

Significant responses to platinum-based chemotherapy in renal medullary carcinoma.

Proteasome inhibitors in cancer therapy: lessons from the first decade.

P31

scholarly article

P356

10.1002/PBC.26402

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcus A Carden

P577

2017-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28052556

http://www.w3.org/2001/XMLSchema#string